We will present Bialoom’s unique silicon plasmonic biosensing technology and how this is used for next generation blood diagnostics in point of care settings. The talk will give an overview of monolithic co-integration of CMOS-compatible Mach Zehnder interferometers with plasmonic transducers and how those are transformed into robust, and configurable biosensor PICs. We will review the capabilities of this technology and we will present the progress towards the development of a powerful plasmo-photonic diagnostic biochip for faster diagnosis and therapy of acute infections.
Dimitris Tsiokos (CEO) obtained his Bachelor (BEng) degree in Electronic Engineering from the University of Southampton, UK in 2001, and his Masters (MSc) degree in Optics & Photonics from Imperial College London, UK in 2002. In 2007 he completed his PhD degree at the National Technical University of Athens. In 2009, Dr Tsiokos was a visiting researcher at the School of Engineering, University of Wisconsin, USA, while he also joined the Centre for Research and Technology (CERTH) and the Aristotle University of Thessaloniki in Greece. Since 2020 he is the CEO of Bialoom, a photonic biosensing technology startup that aims to accelerate diagnosis and therapy of acute infections. His technological interest spin around silicon photonics, plasmonics, biosensing and point of care diagnostics. Dimitris has authored and co‐authored more than 70 publications in peer‐reviewed journals and international conference proceedings, 4 book chapters and 3 patents.